Soranib
Brand Name: Soranib
Composition: Sorafenib Tablets 200 mg
Manufacturer: Cipla
Quantity: 120 Tablets
Category: Pharmacy Medicine
Product Description
Medical Info
Soranib, manufactured by Cipla, is a prescription pharmaceutical containing 200 mg of the active ingredient Sorafenib. Classified as a multikinase inhibitor, it is primarily utilized as a targeted therapy for the management of advanced-stage cancers, specifically including metastatic renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). This medicine works by effectively interfering with the signaling pathways that promote the growth of cancer cells and the development of new blood vessels that feed tumors. Provided in a bottle of 120 tablets, Soranib offers healthcare professionals a crucial specialized option for treating patients with specific malignancies.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
